Drug intelligence / Profile preview

TYNADOTE + n-acetylcysteine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intravenous, Inhalation
01

Overview

TYNADOTE + n-acetylcysteine is a combination product that includes TYNADOTE, which is itself a branded formulation of acetylcysteine (N-acetylcysteine, NAC), a small molecule medication. Acetylcysteine is primarily a mucolytic agent and is widely used as the specific antidote for acetaminophen (paracetamol) overdose, mediating its effect predominantly by replenishing levels of glutathione in the liver, thus preventing or mitigating hepatic injury. It also exerts antioxidant, anti-inflammatory, and mucolytic effects, with clinical applications in conditions such as chronic obstructive pulmonary disease (COPD), contrast-induced nephropathy, and certain fibrotic and inflammatory diseases[1][2][3][4][5]. The exact formulation, dosing, and regulatory status of TYNADOTE as a distinct branded product may vary by jurisdiction; in the context above, it is treated as synonymous with an acetylcysteine preparation.

02

Targets

GSH (Glutathione)MUC2 (Mucin-2)

Beyond the preview

Go deeper on TYNADOTE + n-acetylcysteine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TYNADOTE + n-acetylcysteine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call